Terms of Use

Copyright Status

Most of the information on our site is in the public domain and can be used without charge or restriction unless stated otherwise.

The NIH sponsors most documents on this server; however, you may encounter documents sponsored along with private companies and other organizations. Other parties may retain all rights to publish or reproduce these documents or to allow others to do so. Some documents available from this server may be protected under the U. S. and foreign copyright laws. Permission to reproduce these documents may be required.

Read More >

Disclaimer of Endorsement

NIH does not endorse or recommend any commercial products, processes, or services. The views and opinions of authors expressed on NIH web sites do not necessarily state or reflect those of the U.S. Government, and they may not be used for advertising or product endorsement purposes.

It is not NIH’s intention to provide specific medical advice to users of this web site, instead we provide users with information to help them better understand their health, diagnosed conditions, and the current approaches related to treatment, prevention, screening, and supportive care. NIH urges users to consult with a qualified health care professional for diagnosis and answers to their personal medical questions.

External Links

Some NIH sites may provide links to other Internet sites only for the convenience of World Wide Web users. NIH is not responsible for the availability or content of these external sites, nor does NIH endorse, warrant or guarantee the products, services or information described or offered at these other Internet sites.

Disclaimer of Liability

For documents available from this server, the U.S. Government does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed.

Accessibility Policy

The Type 1 Diabetes TrialNet (TrialNet) ensures that the information available on its Web site is accessible to everyone, pursuant to Section 508 of the Rehabilitation Act. If you use special adaptive equipment to access the Web and you encounter problems when using this site, please contact TrialNet by e-mail. You may wish to request information in an alternative format. Please provide specific details (platform, browser, and page URL) when describing the information that you seek.

To learn more about the regulations governing accessibility, visit the United States Access Board or the official Section 508 page.

Updated: February 9, 2017



If you have any questions about our Terms & Conditions, write to:

Type 1 Diabetes TrialNet Hub
Benaroya Research Institute
1201 Ninth Avenue Seattle, WA  98101 Info@trialnet.org